|
"hc chiu"的相關文件
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2015 |
Xanthohumol from Humulus lupulus L
|
WJ, Lu;CC, Chang;LM, Lien;TL, Yen;HC, Chiu;SY, Huang;KH, Sheu JR & Lin |
| 大葉大學 |
2014-03-18 |
Neuropeptide affected protein expression in the gonad of tilapia in vitro
|
HC, Chiu;CH, Chou;JH, Chen;Shang, Chang Yun;Lin, Lee Tai;Chi, Tang Pin;Tung, Huang Wei |
| 大葉大學 |
2014-03-18 |
Gonadotropins affected the in vitro expression of neuropeptide and steroidogenesis in the gonad of tilapia
|
CH, Chou;HC, Chiu;LT, Wu;CH, Chen;YR, Kang;Shang, Chang Yun;Lin, Lee Tai;Tung, Huang Wei |
| 臺北醫學大學 |
2014 |
Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo
|
ZC, Lien LM & Chen;CL, Chung;TL, Yen;HC, Chiu;DS, Chou;SY, Huang;JR, Sheu;WJ, Lu;KH, Lin |
| 臺北醫學大學 |
2014 |
Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo
|
LM, Lien;ZC, Chen;CL, Chung;TL, Yen;HC, Chiu;DS, Chou;SY, Huang;JR, Sheu;WJ, Lu;KH, Lin |
| 臺北醫學大學 |
2014 |
Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLC γ 2-PKC and MAPK Pathways
|
TL, Yen;WJ, Lu;LM, Lien;PA, Thomas;TY, Lee;HC, Chiu;JR, Sheu;KH, Lin |
| 臺北醫學大學 |
2014 |
Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLC γ 2-PKC and MAPK Pathways
|
TL, Yen;WJ, Lu;LM, Lien;PA, Thomas;TY, Lee;HC, Chiu;JR, Sheu;KH, Lin |
| 臺北醫學大學 |
2014 |
Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo
|
LM, Lien;ZC, Chen;CL, Chung;TL, Yen;HC, Chiu;DS, Chou;SY, Huang;JR, Sheu;WJ, Lu;KH, Lin |
| 臺北醫學大學 |
2014 |
Cardiac autonomic status is associated with spasticity in post-stroke patients
|
CY, Hung;SH, Tseng;SC, Chen;HC, Chiu;CH, Lai;JH, Kang |
| 臺北醫學大學 |
2014 |
The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease
|
JS, Jeng;Sun, Y;JT, Lee;RT, Lin;CH, Chen;HL, Po;HJ, Lin;CH, Liu;MH, Sun;MC, Sun;CM, Chern;LM, Lien;HC, Chiu;HH, Hu;HY, Chiou |
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
